These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extrapyramidal symptoms after addition of fluvoxamine to clozapine. Kuo FJ; Lane HY; Chang WH J Clin Psychopharmacol; 1998 Dec; 18(6):483-4. PubMed ID: 9864083 [No Abstract] [Full Text] [Related]
6. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin. Jakob F; Wolf J Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891 [No Abstract] [Full Text] [Related]
7. Fluvoxamine and mandibular dystonia. Chong SA Can J Psychiatry; 1995 Sep; 40(7):430-1. PubMed ID: 8548729 [No Abstract] [Full Text] [Related]
8. [Extrapyramidal movement disorders after "Isostar Cocktail"]. Staudt F; Linder M Monatsschr Kinderheilkd; 1992 Nov; 140(11):808-10. PubMed ID: 1470186 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
10. Persistent dyskinesia in a patient receiving fluoxetine. Budman CL; Bruun RD Am J Psychiatry; 1991 Oct; 148(10):1403. PubMed ID: 1897625 [No Abstract] [Full Text] [Related]
11. Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine. Arnott S; Nutt D Br J Psychiatry; 1994 Jun; 164(6):838-9. PubMed ID: 7952994 [No Abstract] [Full Text] [Related]
12. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Andrew HG Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668 [TBL] [Abstract][Full Text] [Related]
14. Fluvoxamine-induced acute exacerbation in residual schizophrenia. Rocco PL; De Leo D Pharmacopsychiatry; 1992 Sep; 25(5):245. PubMed ID: 1409869 [No Abstract] [Full Text] [Related]
15. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Casey DE Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821 [No Abstract] [Full Text] [Related]
16. Severe myoclonus produced by fluvoxamine. Bauer M J Clin Psychiatry; 1995 Dec; 56(12):589-90. PubMed ID: 8530337 [No Abstract] [Full Text] [Related]
17. Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression. Suzuki Y; Tsuneyama N; Fukui N; Sugai T; Watanabe J; Ono S; Someya T Hum Psychopharmacol; 2010 Nov; 25(7-8):525-9. PubMed ID: 20860067 [TBL] [Abstract][Full Text] [Related]
18. Psychological factors in susceptibility to drug-induced extrapyramidal symptoms. Levinson P; Malen R; Hogben G; Smith H Am J Psychiatry; 1978 Nov; 135(11):1375-6. PubMed ID: 707640 [TBL] [Abstract][Full Text] [Related]
20. [Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression]. Peyre F; Verdoux H; Bourgeois M Encephale; 1992 Jan; 18 Spec No 1():73-4. PubMed ID: 1600911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]